You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mutations

Showing 1 - 25 of 6,995
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

Not yet recruiting
  • Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)
  • +2 more
    • (no location specified)
    Aug 25, 2023

    Resistance-associated Mutations in Metastatic Lung Cancer

    Recruiting
    • Lung Cancer
    • Liquid biopsy
    • Monza, MB, Italy
      Fondazione IRCCS San Gerardo dei Tintori
    Oct 10, 2023

    Acute Lymphoblastic Leukemia, With Appropriate Mutations, Acute Myeloid Leukemia, With NPM1 Mutations Trial (ziftomenib)

    Available
    • Acute Lymphoblastic Leukemia, With Appropriate Mutations
    • Acute Myeloid Leukemia, With NPM1 Mutations
    • (no location specified)
    Feb 10, 2023

    Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

    Recruiting
    • Core Binding Factor Acute Myeloid Leukemia
    • KIT Mutation-Related Tumors
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Apr 7, 2023

    Advanced Solid Tumors With MAPK Pathway Mutations Trial in Nedlands (D3S-002)

    Not yet recruiting
    • Advanced Solid Tumors With MAPK Pathway Mutations
    • Nedlands, Western Australia, Australia
      D3 Bio Investigative Site
    May 24, 2023

    Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) Trial (DB-OTO)

    Not yet recruiting
    • Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
    • DB-OTO
    • (no location specified)
    Mar 28, 2023

    Single Cell Mutations inPanel of Known Oncogenes in NSCLC

    Recruiting
    • NSCLC
    • Tapestry technology
    • Monza, MB, Italy
      Fondazione IRCCS San Gerardo dei Tintori
    Sep 15, 2023

    NSCLC Trial in Guangzhou (Neratinib tablets)

    Not yet recruiting
    • NSCLC
    • Neratinib tablets
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 1, 2023

    Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)

    Not yet recruiting
    • Gastric
    • Colorectal Adenocarcinoma
    • Shenyang, Liaoning, China
      Liaoning Cancer Hospital & Institute
    Nov 1, 2023

    Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction

    Not yet recruiting
    • Hiv
    • +5 more
    • differences in CD4 reconstruction
    • (no location specified)
    Sep 17, 2023

    NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • MK-2870
    • +2 more
    • (no location specified)
    Oct 3, 2023

    Sodium Channel Mutations in Anterior Cutaneous Nerve Entrapment

    Not yet recruiting
    • Anterior Cutaneous Nerve Entrapment Syndrome
    • +2 more
    • Sodium channel mutation
    • Veldhoven, Netherlands
      Maxima Medical Center
    May 26, 2023

    NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

    Not yet recruiting
    • NSCLC
    • +2 more
    • Guangzhou, Guangdong, China
      Cancer Center of Sun-Yat Sen University
    Sep 19, 2023

    Duchenne Muscular Dystrophy With Small Mutations

    Recruiting
    • Muscular Dystrophy, Duchenne
    • MUSCLE MAGNETIC RESONANCE IMAGING (MRI)
    • Rome, Italy
      Claudia Brogna
    Apr 17, 2023

    Clinical Implications for NSCLC Patients With Rare Mutations

    Recruiting
    • NSCLC
    • +2 more
      • Shanghai, Shanghai, China
      • +1 more
      Jan 18, 2023

      NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

      Recruiting
      • Non-small Cell Lung Cancer
      • SH-1028 tablets
      • Placebo SH-1028 tablets
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Oct 6, 2023

      PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)

      Completed
      • PIK3CA Mutation-Related Tumors
      • Shanghai, Shanghai, China
        Shanghai East Hospital
      Nov 9, 2023

      NSCLC Trial in Singapore (Afatinib 40 MG)

      Not yet recruiting
      • NSCLC
      • Afatinib 40 MG
      • Singapore, Singapore
        National University Hospital
      Sep 25, 2023

      Azole Resistance Inducing Mutations on DNA Extracted Directly

      Recruiting
      • Invasive Aspergillosis
      • Aspergillus PCR
      • Rotterdam, Zuid Holland, Netherlands
        Erasmus Medical Center (EMC)
      Oct 5, 2023

      LPIN1 Mutations Treated With Low Dose Hydroxychloroquine Sulfate

      Not yet recruiting
      • Lipin-1 Deficiency
        • (no location specified)
        Sep 29, 2022

        Positron Emission Tomography Imaging in People With Gaucher

        Completed
        • Parkinson Disease
        • Gaucher Disease
        • 15-0 H20
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 18, 2023

        PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome Trial in Stanford, Boston, Cleveland (Sirolimus,

        Not yet recruiting
        • PTEN Gene Mutation
        • +2 more
        • Stanford, California
        • +2 more
        Oct 5, 2023

        Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

        Not yet recruiting
        • Advanced or Metastatic Solid Tumors
        • (no location specified)
        Jun 21, 2023

        Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)

        Recruiting
        • Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
        • Shanghai, Shanghai, China
          The Obstetrics & Gynecology Hospital of Fudan University (Shangh
        Nov 3, 2023

        NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • +2 more
        • Fairfax, Virginia
          NEXT Virginia
        Sep 18, 2023